Short interest for Nanalysis Scientific gives investors a sense of the degree to which investors are betting on the decline of Nanalysis Scientific's stock. Short interest data is updated every two weeks.

Nanalysis Scientific Stock (OTC:NSCIF), Short Interest Report

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Penny Stocks

Small Cap

Markets

ADVZF

ARREF

ASMIY

BDRAF

BDRBF

CCNB

CNIG

CNIGO

CNIGP

CNSNF

CRSXF

CTSDF

DYLLF

ELRRF

ENZN

ETCG

ETHE

FCUUF

FFNTF

FLMMF

GBTC

GDLC

GDNSF

GLOBAL ATOMIC CORP by Global Atomic Corp.

GLATF

GRRB

HEOFF

IPOOF

ISENF

IVPAF

JRNGF

MLNLF

MRMD

MRVFF

NDVAF

NIOBF

NKOSF

NNXPF

NSCIF

NTTHF

NVNXF

OBELF

OPSSF

OTCM

POETF

PTRUF

SVBT

TAALF

TBTC

THBRF

TRBMF

UNRIVALED BRANDS INC by Unrivaled Brands, Inc.

UNRV

WOWMF

WSTRF

YZCAY

YZCHF

Photo by Yiorgos Ntrahas on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

The 2022 OTCQX Best 50 Has Been Announced — Here Are The Companies That Made The Cut

NANALYSIS SCIENTIFIC CORP by Nanalysis Scientific Corp.

Nanalysis Scientific Corp

Since a scathing report about the woeful inadequacies of New York's legal cannabis program <a href="https://www.benzinga.com/markets/cannabis/24/05/38773372/scathing-internal-report-exposes-new-yorks-cannabis-agency-as-inexperienced-irresponsible-ineffe">hit the airwaves Friday</a>, which included a shakeup within the <a href="https://www.benzinga.com/topic/office-of-cannabis-management">Office of Cannabis Management</a> (OCM), Governor Kathy Hochul (D) announced a complete overhaul of the agency responsible for the repeatedly botched launch of N.Y.'s adult-use marijuana program.
"Now I've been frank with New Yorkers that I'm not satisfied. I even used the word disaster to describe the status quo," Gov. Hochul said. 
Confirming her commitment to establish the nation&#8217;s most equitable cannabis industry, Hochul proposed reforms to address the numerous issues head-on. 
"We promised to build the strongest, most equitable legal cannabis market in the nation, and we're announcing long-needed steps to make New York's cannabis program work as promised," Hochul said.
<h2 class="wp-block-heading">How Exactly? Unclog The Licensing Bottleneck</h2>
The governor announced various recommendations that focus on streamlining the licensing process, combating illicit smoke shops and vendors and bolstering communication between the state and licensees.
"There are deep-seated issues at OCM — issues that have limited its ability to fulfill its licensing role," Hochul said in a speech in Albany, <a href="https://www.silive.com/news/2024/05/ny-gov-hochul-to-overhaul-office-of-cannabis-management-following-disaster-rollout-of-legal-weed.html">reported</a> SILive.com. "We are going to unclog the licensing bottleneck."
<h2 class="wp-block-heading">Details, Please</h2>
Key measures include revamping internal procedures, eliminating application backlogs and implementing a service-level agreement to ensure timely processing of retail license applications within 90 days.
Efforts will be undertaken to enhance staffing levels and develop a comprehensive five-year strategic plan for the agency&#8217;s future, following the ouster of OCM's first director Chris Alexander, who will step down at the end of his term in September.
To support equity in the cannabis industry, a $5 million grant program will be established for retail cannabis license holders, particularly those with prior cannabis-related convictions. These entrepreneurs, by the way, faced significant financial losses due to licensing delays stemming from <a href="https://www.benzinga.com/markets/cannabis/23/08/33617244/the-debacle-called-ny-cannabis-market-state-supreme-court-halts-new-retail-licenses-following-ve">legal disputes</a>. They will now receive assistance to kickstart their businesses.
<h2 class="wp-block-heading">And Then There's This: Rampant Illegal Weed Market</h2>
The state will intensify efforts to curb the illegal cannabis market, which can safely be said to be out of control. Authorities confirm there are more than <a href="https://www.benzinga.com/markets/cannabis/23/08/33851213/nyc-landlords-face-10-grand-in-fines-if-they-rent-to-illicit-weed-shops-law-goes-into-effect">2,000 illicit shops</a> operating in New York City alone. To shutter them, Hochul unveiled the creation of a Cannabis Enforcement Task Force tasked with inspecting and shutting down them down.
New York State Police Superintendent Steven G. James vowed to get involved in the crackdown. "The State Police will work with its partners to target those who are bringing illegal Cannabis into New York, disrupt their operation and hold them accountable to the full extent of the law."
Read now: <a href="https://www.benzinga.com/markets/cannabis/24/05/38773372/scathing-internal-report-exposes-new-yorks-cannabis-agency-as-inexperienced-irresponsible-ineffe">Scathing Internal Report Exposes New York&#8217;s Cannabis Agency As Inexperienced, Irresponsible, Ineffective: Heads Are Rolling</a>
Image generated using artificial intelligence via Midjourney.

Cannabis

Government

News

Regulations

Politics

NY Cannabis Office Overhauled: Gov. Hochul Plans To 'Unclog The Licensing Bottleneck'

WIIM

FFIE

LCID

RIVN

Shares of EV stocks are trading higher on reports indicating Biden will increase Chinese EV tariffs.

Editor&#8217;s note: This story has been corrected to reflect that Curaleaf is headquartered in New York City. 
Curaleaf CEO Matt Darin told Benzinga at the<a href="https://www.benzinga.com/events/cannabis-conference/fall-2024/">&nbsp;Cannabis Capital Conference&nbsp;</a>in Miami that the company has recently increased its <a href="https://www.benzinga.com/topic/new-york-cannabis">presence in New York</a>.
The New York City-based company enhanced its retail spaces to serve both medical and adult-use cannabis markets.
&#8220;In many states, we&#8217;ve navigated the transition from medical to adult use,&#8221; Darin noted. The strategy focuses on ensuring uninterrupted product supply for medical patients while accommodating a surge in new customers. 
Darin also highlighted the success of the company&#8217;s first co-located medical and adult-use store in Newberg, Hudson Valley, expressing excitement about upcoming store openings.
<h3 class="wp-block-heading">Commitment To Social Equity</h3>
Curaleaf&#8217;s commitment to social equity, particularly in its hiring practices, is a major factor in its operations. The company strives to hire at least 10% of its workforce from communities disproportionately affected by past drug policies. 
&#8220;We have a robust corporate social responsibility program,&#8221; Darin emphasized, underscoring the importance of partnerships and initiatives like their collaboration with Bernard Noble and Fab Five Freddy in New York. 
These initiatives are part of a broader strategy to integrate and contribute to the communities they serve, showcasing Curaleaf&#8217;s dedication to making a positive difference.
<h3 class="wp-block-heading">Global Perspectives On Cannabis</h3>
At the Benzinga Cannabis Capital Conference, Darin expressed his enthusiasm for the networking opportunities presented by the gathering of industry leaders and investors. 
&#8220;It&#8217;s encouraging to see a record number of attendees and continued interest in the industry,&#8221; he said, highlighting the importance of community and connections.
Reflecting on the discussions from the panel he participated in, Darin mentioned the increasing global interest in cannabis legalization. 
&#8220;There is a growing awareness that cannabis legalization is happening globally, not just in the U.S.,&#8221; he explained. This perspective is essential as Curaleaf considers its future growth opportunities, particularly in Europe.
Curaleaf, under Darin&#8217;s leadership, continues to strengthen its market presence while focusing on community engagement and global expansion. 
The company&#8217;s efforts to balance patient care with market demands in New York serve as a model for its operations in other states and potentially worldwide.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Matt Darin &#x7C; Curaleaf" width="500" height="281" src="https://www.youtube.com/embed/8Tf5enVHCx0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly for top executives, investors, and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.&nbsp;<a target="_blank" href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener">Get your tickets now</a>&nbsp;before prices surge by following&nbsp;<a target="_blank" href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener">this link</a>.
Now Read: <a href="https://www.benzinga.com/markets/cannabis/24/04/38366824/struggling-new-york-cannabis-farmers-excluded-from-state-budget-relief-fund-is-dismissed">Struggling New York Cannabis Farmers Excluded From State Budget, Relief Fund Is Dismissed</a>
Image: Curaleaf/Linkedin

Events

Exclusives

Interview

Curaleaf's Dual Expansion: Balancing Medical And Recreational Markets While Emphasizing Social Equity (CORRECTED)

Whales with a lot of money to spend have taken a noticeably bearish stance on Guardant Health.
Looking at options history for Guardant Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $157,232 and 9, calls, for a total amount of $450,285.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $30.0 for Guardant Health over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Guardant Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Guardant Health's whale trades within a strike price range from $15.0 to $30.0 in the last 30 days. 
<h3>Guardant Health 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715627770_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/17/24</td>
<td>$4.4</td>
<td>$3.7</td>
<td>$4.0</td>
<td>$20.00</td>
<td>$80.0K</td>
<td>9.0K</td>
<td style="text-align: right;">527</td>
</tr>
<tr>
<td>GH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$1.75</td>
<td>$1.35</td>
<td>$1.6</td>
<td>$22.50</td>
<td>$80.0K</td>
<td>2.1K</td>
<td style="text-align: right;">617</td>
</tr>
<tr>
<td>GH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/17/24</td>
<td>$1.7</td>
<td>$1.5</td>
<td>$1.5</td>
<td>$22.50</td>
<td>$75.0K</td>
<td>2.1K</td>
<td style="text-align: right;">617</td>
</tr>
<tr>
<td>GH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.1</td>
<td>$2.9</td>
<td>$3.1</td>
<td>$20.00</td>
<td>$57.6K</td>
<td>2.0K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>GH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$4.3</td>
<td>$3.4</td>
<td>$4.25</td>
<td>$20.00</td>
<td>$56.9K</td>
<td>9.0K</td>
<td style="text-align: right;">315</td>
</tr>
</tbody>
</table>

<h3>About Guardant Health</h3>
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Having examined the options trading patterns of Guardant Health, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Guardant Health</h3>
<ul>
<li>Currently trading with a volume of 2,685,790, the GH's price is up by 6.77%, now at $23.89. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 80 days.</li>
</ul>
<h3>What Analysts Are Saying About Guardant Health</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $28.666666666666668.
<ul>
<li>An analyst from Goldman Sachs has decided to maintain their Buy rating on Guardant Health, which currently sits at a price target of $28. </li>
<li>Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Guardant Health with a target price of $30. </li>
<li>An analyst from Craig-Hallum has revised its rating downward to Buy, adjusting the price target to $28. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Guardant Health, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Market Whales and Their Recent Bets on Guardant Health Options

Whales with a lot of money to spend have taken a noticeably bearish stance on Humana.
Looking at options history for Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $320,328 and 9, calls, for a total amount of $309,620.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $450.0 for Humana over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Humana options trades today is 307.22 with a total volume of 1,870.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Humana's big money trades within a strike price range of $300.0 to $450.0 over the last 30 days.
<h3>Humana Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715627765_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$111.2</td>
<td>$105.9</td>
<td>$109.28</td>
<td>$450.00</td>
<td>$152.9K</td>
<td style="text-align: right;">76</td>
<td style="text-align: right;">26</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$111.2</td>
<td>$105.9</td>
<td>$109.62</td>
<td>$450.00</td>
<td>$87.6K</td>
<td style="text-align: right;">76</td>
<td style="text-align: right;">11</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$100.7</td>
<td>$97.0</td>
<td>$99.66</td>
<td>$440.00</td>
<td>$79.6K</td>
<td style="text-align: right;">12</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$6.0</td>
<td>$5.6</td>
<td>$6.0</td>
<td>$340.00</td>
<td>$58.2K</td>
<td style="text-align: right;">405</td>
<td style="text-align: right;">407</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$6.6</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$340.00</td>
<td>$36.4K</td>
<td style="text-align: right;">405</td>
<td style="text-align: right;">221</td>
</tr>
</tbody>
</table>

<h3>About Humana</h3>
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
In light of the recent options history for Humana, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Humana Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 771,898, the HUM's price is up by 1.52%, now at $340.69. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 79 days.</li>
</ul>
<h3>What Analysts Are Saying About Humana</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $358.0.
<ul>
<li>Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Humana, targeting a price of $381. </li>
<li>Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Humana, targeting a price of $370. </li>
<li>Maintaining their stance, an analyst from Cantor Fitzgerald continues to hold a Neutral rating for Humana, targeting a price of $360. </li>
<li>Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Humana, targeting a price of $326. </li>
<li>Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Humana, targeting a price of $353. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humana with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Humana Unusual Options Activity

Financial giants have made a conspicuous bullish move on Block. Our analysis of options history for Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) revealed 23 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 43% showed bearish tendencies. Out of all the trades we spotted, 13 were puts, with a value of $776,916, and 10 were calls, valued at $585,340.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $130.0 for Block over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Block stands at 3964.83, with a total volume reaching 3,924.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Block, situated within the strike price corridor from $35.0 to $130.0, throughout the last 30 days.
<h3>Block 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715627759_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SQ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$7.1</td>
<td>$6.95</td>
<td>$6.95</td>
<td>$70.00</td>
<td>$236.3K</td>
<td>3.1K</td>
<td style="text-align: right;">361</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$17.25</td>
<td>$17.0</td>
<td>$17.0</td>
<td>$80.00</td>
<td>$170.0K</td>
<td>4.2K</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.15</td>
<td>$3.05</td>
<td>$3.05</td>
<td>$105.00</td>
<td>$66.5K</td>
<td>2.6K</td>
<td style="text-align: right;">218</td>
</tr>
<tr>
<td>SQ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$6.5</td>
<td>$6.45</td>
<td>$6.45</td>
<td>$75.00</td>
<td>$64.5K</td>
<td>3.4K</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.95</td>
<td>$8.9</td>
<td>$8.9</td>
<td>$80.00</td>
<td>$61.4K</td>
<td>3.6K</td>
<td style="text-align: right;">210</td>
</tr>
</tbody>
</table>

<h3>About Block</h3>
Founded in 2009, Block provides payment services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. In 2023, Square's payment volume was a little over $200 million.
<h3>Current Position of Block</h3>
<ul>
<li>Currently trading with a volume of 5,207,013, the SQ's price is up by 0.97%, now at $72.0. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 80 days.</li>
</ul>
<h3>What Analysts Are Saying About Block</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $98.8.
<ul>
<li>An analyst from Needham has decided to maintain their Buy rating on Block, which currently sits at a price target of $105. </li>
<li>Consistent in their evaluation, an analyst from Baird keeps a Outperform rating on Block with a target price of $98. </li>
<li>Reflecting concerns, an analyst from Benchmark lowers its rating to Buy with a new price target of $99.</li>
<li>An analyst from TD Cowen has decided to maintain their Buy rating on Block, which currently sits at a price target of $92. </li>
<li>Consistent in their evaluation, an analyst from Baird keeps a Outperform rating on Block with a target price of $100. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Block, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Block Options Trading: A Deep Dive into Market Sentiment

Henkel AG &amp; Co. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/henky#OTC">HENKY</a>) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company&#39;s changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Henkel AG &amp; Co. is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock Prices
The change in a company&#39;s future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company&#39;s shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Henkel AG &amp; Co. imply an improvement in the company&#39;s underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate Revisions
As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Earnings Estimate Revisions for Henkel AG &amp; Co.
For the fiscal year ending December 2024, this company is expected to earn $1.27 per share, which is a change of 8.6% from the year-ago reported number.
Analysts have been steadily raising their estimates for Henkel AG &amp; Co. Over the past three months, the Zacks Consensus Estimate for the company has increased 1.2%.
Bottom Line
Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of &#39;buy&#39; and &#39;sell&#39; ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a &#39;Strong Buy&#39; rating and the next 15% get a &#39;Buy&#39; rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
The upgrade of Henkel AG &amp; Co. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
<a href="https://www.zacks.com/stock/news/2273032/all-you-need-to-know-about-henkel-ag-co-henky-rating-upgrade-to-buy?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2273032">To read this article on Zacks.com click here.</a>

Earnings

Upgrades

Analyst Ratings

Trading Ideas

HENKY

All You Need to Know About Henkel AG & Co. Rating Upgrade to Buy

Virtu Financial (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virt#NASDAQ">VIRT</a>) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company&#39;s changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Virtu Financial is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock Prices
The change in a company&#39;s future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company&#39;s shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Virtu Financial imply an improvement in the company&#39;s underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate Revisions
As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Earnings Estimate Revisions for Virtu Financial
For the fiscal year ending December 2024, this high-speed trading company is expected to earn $2.34 per share, which is a change of 27.2% from the year-ago reported number.
Analysts have been steadily raising their estimates for Virtu Financial. Over the past three months, the Zacks Consensus Estimate for the company has increased 13.1%.
Bottom Line
Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of &#39;buy&#39; and &#39;sell&#39; ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a &#39;Strong Buy&#39; rating and the next 15% get a &#39;Buy&#39; rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
The upgrade of Virtu Financial to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
<a href="https://www.zacks.com/stock/news/2273033/virtu-financial-virt-upgraded-to-strong-buy-here-s-what-you-should-know?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2273033">To read this article on Zacks.com click here.</a>

VIRT

Virtu Financial Upgraded to Strong Buy: Here's What You Should Know

Baidu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bidu#NASDAQ">BIDU</a>) is scheduled to report first-quarter 2024 results on May 16. 
The Zacks Consensus Estimate for revenues is pegged at $4.31 billion, indicating a decline of 4.9% from the year-ago quarter&#39;s reported figure. 
The Zacks Consensus Estimate for earnings is pegged at $2.30 per share, suggesting a 1.7% fall from the prior-year quarter&#39;s reported figure. The estimated figure has remained unchanged over the past 30 days. 
BIDU&#39;s earnings beat estimates in the trailing four quarters, the average being 17.14%.
<div class="chart_embed">
<h3>Baidu, Inc. Price and EPS Surprise</h3>
<a href="https://www.zacks.com/stock/chart/BIDU/price-eps-surprise?icid=chart-BIDU-price-eps-surprise"><img alt="Baidu, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/18/1715602793.png" style="height:299px; width:620px" title="" /> </a>
Baidu, Inc. price-eps-surprise | Baidu, Inc. Quote
</div>
<h3>Factors to Consider</h3>
Baidu&#39;s first-quarter 2024 results are likely to have benefited from its strengthening AI business, driven by the growing momentum of ERNIE Bot across China. 
Strength across Baidu Cloud is likely to have been another key catalyst for its AI business. 
The company&#39;s increasing focus on bolstering its ad technologies by introducing AI chatbots for brands, enabling them to enhance user engagement and drive customer demand, is expected to have been a tailwind in the to-be-reported quarter. 
Baidu&#39;s expanding partnerships with companies like Samsung, Honor and Autohome, which integrates ERNIE API into their own products, are expected to have further solidified its position as a leader in the generative AI market. 
Strength in Apollo Go Robotaxi service across China, on the back of its ongoing efforts to expand its operating area and intensify operations during peak hours in areas with complex traffic conditions, is likely to have aided Baidu&#39;s intelligent driving business during the quarter under review. 
Growing momentum in Baidu&#39;s mobile ecosystem is expected to have aided growth in the average daily active user base of the Baidu App in the first quarter. 
The company&#39;s growing R&amp;D efforts to enable enterprises and developers to use less advanced chips for efficient model training and inferencing are likely to have provided Baidu with a competitive advantage over its domestic peers in the to-be-reported quarter. 
However, the impacts of higher channel spending, promotional expenses and heavy spending on new growth areas are expected to have affected the company&#39;s performance in the first quarter. 
Further, broad-based weakness in China is anticipated to have negatively impacted the company during the quarter under review. 
The intensifying competitive landscape in generative AI and large language model markets is likely to have been a headwind.
<h3>What Our Model Says</h3>
According to the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that&#39;s not the case here. 
Baidu has an Earnings ESP of 0.00% and currently carries a Zacks Rank #4 (Sell).
<h3>Stocks to Consider</h3>
Here are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases: 
NVIDIA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) has an Earnings ESP of +2.50% and a Zacks Rank #1 at present. 
NVIDIA is scheduled to release first-quarter fiscal 2025 results on May 22. The Zacks Consensus Estimate for NVDA&#39;s earnings is pegged at $5.49 per share, suggesting a significant jump from the prior-year quarter&#39;s reported figure of $1.09 per share. 
Abercrombie &amp; Fitch (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anf#NYSE">ANF</a>) has an Earnings ESP of +5.10% and a Zacks Rank #2 at present. 
Abercrombie &amp; Fitch is set to report first-quarter 2024 results on May 29. The Zacks Consensus Estimate for ANF&#39;s earnings is pegged at $1.54 cents per share, indicating a significant jump from the year-ago quarter&#39;s reported figure of 39 cents per share. 
Costco Wholesale (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cost#NASDAQ">COST</a>) has an Earnings ESP of +0.07% and a Zacks Rank #3 at present. 
Costco Wholesale is set to report its third-quarter fiscal 2024 results on May 30. The Zacks Consensus Estimate for COST&#39;s earnings is pegged at $3.69 per share, suggesting a 7.6% growth from the prior-year quarter&#39;s reported figure. 
<a href="https://www.zacks.com/stock/news/2272927/baidu-bidu-to-report-q1-earnings-what-s-in-the-offing?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2272927">To read this article on Zacks.com click here.</a>

Asia

Tech

BIDU

COST

NVDA

Baidu to Report Q1 Earnings: What's in the Offing?

Investors interested in Computer and Technology stocks should always be looking to find the best-performing companies in the group. Is Nvidia (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) one of those stocks right now? A quick glance at the company&#39;s year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question.
Nvidia is a member of our Computer and Technology group, which includes 619 different companies and currently sits at #9 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Nvidia is currently sporting a Zacks Rank of #1 (Strong Buy).
Within the past quarter, the Zacks Consensus Estimate for NVDA&#39;s full-year earnings has moved 20.7% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, NVDA has returned 81.5% so far this year. Meanwhile, stocks in the Computer and Technology group have gained about 12.8% on average. This means that Nvidia is performing better than its sector in terms of year-to-date returns.
Another stock in the Computer and Technology sector, Onto Innovation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/onto#NYSE">ONTO</a>), has outperformed the sector so far this year. The stock&#39;s year-to-date return is 46.7%.
The consensus estimate for Onto Innovation&#39;s current year EPS has increased 2.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Nvidia belongs to the Semiconductor - General industry, which includes 8 individual stocks and currently sits at #189 in the Zacks Industry Rank. On average, stocks in this group have gained 56.7% this year, meaning that NVDA is performing better in terms of year-to-date returns.
On the other hand, Onto Innovation belongs to the Nanotechnology industry. This 2-stock industry is currently ranked #27. The industry has moved +43.8% year to date.
Investors interested in the Computer and Technology sector may want to keep a close eye on Nvidia and Onto Innovation as they attempt to continue their solid performance.
<a href="https://www.zacks.com/stock/news/2272790/is-nvidia-nvda-outperforming-other-computer-and-technology-stocks-this-year?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_1-2272790">To read this article on Zacks.com click here.</a>

ONTO

Is NVIDIA Outperforming Other Computer and Technology Stocks This Year?

Have you assessed how the international operations of GoPro (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gpro#NASDAQ">GPRO</a>) performed in the quarter ended March 2024? For this action video camera maker, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.
The global economy today is deeply interlinked, making a company&#39;s engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this understanding reveals the firm&#39;s potential for consistent earnings, its capacity to harness different economic cycles, and its overall growth prospects.
Being present in international markets serves as a counterbalance to domestic economic challenges while offering chances to engage with more rapidly evolving economies. However, this kind of diversification introduces challenges like currency fluctuations, geopolitical uncertainties and varying market trends.
Upon examining GPRO&#39;s recent quarterly performance, we noticed several interesting patterns in the revenue generated from its international segments, which are commonly analyzed and observed by Wall Street experts.
The company&#39;s total revenue for the quarter amounted to $155.47 million, showing decrease of 11%. We will now explore the breakdown of GPRO&#39;s overseas revenue to assess the impact of its international operations.
Decoding GPRO&#39;s International Revenue Trends
During the quarter, Europe, Middle East and Africa contributed $52.01 million in revenue, making up 33.5% of the total revenue. When compared to the consensus estimate of $42.06 million, this meant a surprise of +23.65%. Looking back, Europe, Middle East and Africa contributed $94.81 million, or 32.1%, in the previous quarter, and $46.02 million, or 26.3%, in the same quarter of the previous year.
Asia and Pacific area countries generated $26.86 million in revenues for the company in the last quarter, constituting 17.3% of the total. This represented a surprise of -24.07% compared to the $35.38 million projected by Wall Street analysts. Comparatively, in the previous quarter, Asia and Pacific area countries accounted for $73.71 million (25%), and in the year-ago quarter, it contributed $39.19 million (22.4%) to the total revenue.
Projected Revenues in Foreign Markets
For the current fiscal quarter, it is anticipated by Wall Street analysts that GoPro will report a total revenue of $170.71 million, which reflects a decline of 29.2% from the same quarter in the previous year. The revenue contributions are expected to be 38.3% from Europe, Middle East and Africa ($65.41 million) and 32.1% from Asia and Pacific area countries ($54.87 million).
For the full year, the company is expected to generate $932.6 million in total revenue, down 7.3% from the previous year. Revenues from Europe, Middle East and Africa and Asia and Pacific area countries are expected to constitute 30.7% ($286.34 million) and 25.7% ($239.93 million) of the total, respectively.
Final Thoughts
The dependency of GoPro on global markets for its revenues presents a mix of potential gains and hazards. Thus, monitoring the trends in its overseas revenues can be a key indicator for predicting the firm&#39;s future performance.
In an era of growing international interdependencies and escalating geopolitical disputes, Wall Street analysts are vigilant in tracking these trends for businesses with a global reach, in order to refine their predictions of earnings. It should be noted, however, that a multitude of other elements, such as a company&#39;s domestic position, also play a significant role in shaping the earnings forecasts.
We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there&#39;s a positive relationship -- upward earnings predictions often result in an increase in stock prices.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
At present, GoPro holds a Zacks Rank #3 (Hold). This ranking implies that its near-term performance might mirror the overall market movement.
Examining the Latest Trends in GoPro&#39;s Stock Value
The stock has declined by 12.6% over the past month compared to the 1.3% rise of the Zacks S&amp;P 500 composite. Meanwhile, the Zacks Consumer Discretionary sector, which includes GoPro, has decreased 2% during this time frame. Over the past three months, the company&#39;s shares have experienced a loss of 32.9% relative to the S&amp;P 500&#39;s 4.3% increase. Throughout this period, the sector overall has witnessed a 4.6% decrease.
<a href="https://www.zacks.com/stock/news/2273004/why-gopro-gpro-international-revenue-trends-deserve-your-attention?cid=CS-BENZ-FT-fundamental_analysis|nfm_international_revenues-2273004">To read this article on Zacks.com click here.</a>

Media

GPRO

Why GoPro International Revenue Trends Deserve Your Attention

GameStop Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), the U.S. video game retail chain, is expanding its market reach by venturing into the lucrative <a href="https://www.benzinga.com/real-estate/22/10/29411566/elon-musks-recommendation-to-invest-in-physical-things-may-be-his-best-advice-yet">collectibles domain. </a>
<a href="https://www.ign.com/articles/gamestop-will-reportedly-begin-buying-and-selling-single-pokmon-and-other-tcg-cards">According</a> to IGN, select GameStop stores will begin buying and selling single Pokémon and other trading cards starting this week. 
The Grapevine, Texas-based company aims to capitalize on the collectibles market, leveraging its existing trade-in system for video games to facilitate transactions for graded trading cards.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38796814/gamestop-stock-pumped-but-what-about-the-gamestop-meme-coin-its-gonna-get-wild-predicts-tr">GameStop Stock Pumps, But What About The GameStop Meme Coin? &#8216;It&#8217;s Gonna Get Wild,&#8217; Predicts Trader</a>
The emphasis is on &#8220;graded&#8221; cards, authenticated and appraised for their condition and authenticity by the Professional Sports Authenticator (PSA). This ensures that only genuine and valuable cards are accepted. 
Initially, GameStop will limit its acceptance to cards graded by PSA and those valued at $500 or less. However, plans are underway to expand this service to all GameStop locations.
GameStop views this move as a natural evolution given the declining significance of physical media in the gaming industry. The company aims to diversify its offerings and tap into the growing popularity of trading card games. Pokémon cards will be a primary focus, with holographic and reverse holographic cards priced at $1 each.
The decision to enter the trading card market comes amidst a surge in interest, fueled by high-profile sales of rare cards fetching millions of dollars. Notably, a Pokémon card holds the record for the most expensive trading card sold at $5.275 million. 
Other instances, such as rapper Post Malone purchasing a Lord of the Rings Magic: The Gathering card for $2 million, underscore the market&#8217;s allure.
Price Action: GameStop&#8217;s stock spiked by more than 100% at one point Monday, <a href="https://www.benzinga.com/news/24/05/38789404/gamestops-rally-resumes-in-may-what-sparked-the-interest">adding billions of dollars in valuation to the video game company.</a> 
Keith Gill (aka Roaring Kitty) <a href="https://www.benzinga.com/news/24/05/38789404/gamestops-rally-resumes-in-may-what-sparked-the-interest">posted on social media for the first time</a> Sunday night in almost three years. Recall how Gill was initially responsible for the 2020 meme stock frenzy.
The stock is currently trading at $31.22 a share and is up 78.5% at last check on Monday. 
Read Next: <a href="https://www.benzinga.com/news/24/05/38796280/is-roaring-kitty-back-for-round-2-gamestop-posts-flood-wallstreetbets-as-traders-eye-massive-gains-w">Is Roaring Kitty Back For Round 2? GameStop Posts Flood WallStreetBets As Traders Eye Massive Gains: &#8216;We Are So Back&#8217;</a>
Image credits: Shutterstock.

Gaming

GameStop Dives Into Collectibles Market With Pokémon Trading Cards

NEGG

Newegg Commerce shares are trading higher amid strength in high-short interest stocks.

JonesTrading analyst Jason Stewart maintains Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) with a Buy and maintains $2.5 price target.

Price Target

JonesTrading Maintains Buy on Lument Finance Trust, Maintains $2.5 Price Target

As the world focuses on sustainability and reducing carbon footprints, clean tech stocks are gaining attention from investors seeking both financial returns<a href="https://www.benzinga.com/topic/esg"> and environmental impact</a>.
Out of the coverage universe of JPMorgan analysts Bill Peterson,&nbsp;Mahima Kakani and Bennett Moore, three clean tech stocks stand out with significant upside potential, offering investors the opportunity to invest in companies at the forefront of the clean energy revolution: Blade Air Mobility Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>), ChargePoint Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) and Enovix Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>).
<h1 class="wp-block-heading">Blade Air Mobility</h1>
Blade Air Mobility&#8217;s strong first quarter performance — with better-than-expected adjusted EBITDA driven by revenue growth in MediMobility and flight margin improvements — highlights its position as a key player in the Urban Air Mobility (UAM) space.
JPMorgan&#8217;s Overweight rating on Blade Air stock reflects its confidence in the company&#8217;s ability to deliver on its positive EBITDA goals in 2024 and 2025. JPMorgan currently rates the company Overweight, citing its path to profitability and opportunities for margin expansion in its Passenger segment. With a price target of $5 representing an upside of 42.9%, Blade remains a preferred way to play the UAM theme.
Blade Air Mobility is an aviation company with an urban air mobility platform that provides air transportation for passengers and last-mile critical cargo. It is developing an electric vertical aircraft (EVA) to be quiet, carbon-neutral and cost-effective.
Also Read: <a href="https://www.benzinga.com/markets/esg/24/03/38004185/2-of-the-top-5-world-economies-can-now-run-100-on-renewable-energy">2 Of The Top 5 World Economies Can Now Run 100% On Renewable Energy</a>
<h1 class="wp-block-heading">ChargePoint</h1>
While the near-term outlook for the overall EV market in North America may be muted, ChargePoint stands out as a potential beneficiary of accelerated fleet demand.
JPMorgan&#8217;s Overweight rating on ChargePoint reflects its belief that owner-operators will continue to benefit from higher throughput on existing stalls, provided they can defend and grow market share. 
With a price target of $5 for December 2024, representing an upside of 226.8%, ChargePoint presents a compelling investment opportunity in the clean tech sector.
ChargePoint operates an online network of independently owned EV charging stations. It also offers technology for charging electric vehicles at home.
<h1 class="wp-block-heading">Enovix</h1>
Enovix&#8217;s recent cost reduction efforts, including layoffs at its California factory, demonstrate its commitment to improving operating efficiency. Despite these challenges, JPMorgan remains bullish on Enovix, citing the U.S. Treasury Department&#8217;s guidance on claiming the IRA&#8217;s Advanced Manufacturing Production Tax Credit as a potential catalyst for the stock.
With a price target of $12 for December 2024, representing an upside of 41.0%, Enovix remains a strong contender in the clean tech space.
Enovix is the developer of 3D silicon lithium-ion rechargeable batteries.
These three stocks offer investors the opportunity to capitalize on the growth potential of the clean tech sector, driven by increasing focus on sustainability and renewable energy sources. As governments and businesses around the world commit to reducing carbon emissions, these companies stand well-positioned to benefit from the shift towards a cleaner, greener future.
Read Next: <a href="https://www.benzinga.com/general/23/10/35270362/how-to-earn-1-000-per-month-from-esg-investing">How To Earn $1,000 Per Month From ESG Investing</a>
Photo: Courtesy Blade Air

Analyst Color

Long Ideas

BLDE

CHPT

ENVX

3 Clean Tech Stocks With Over 40% Upside Per JPMorgan Analysts

Leading electric vehicle company Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is offering a new financing incentive for customers on the Model Y, joining the recent promotional offers on <a href="https://www.benzinga.com/news/earnings/24/01/36768363/tesla-q4-earnings-highlights-revenue-miss-eps-miss-model-y-a-global-bestseller-next-gen-vehicle-upd">the bestselling vehicle.</a>
What Happened: As Tesla addresses concerns about <a href="https://www.benzinga.com/news/24/03/37688367/electric-vehicle-market-slows-down-prompts-major-automakers-to-shift-strategy">electric vehicle demand</a>, the company has introduced a new financing offer on its website.
According to the company's <a href="https://www.tesla.com/modely">website</a>, consumers can purchase a Model Y at 0.99% APR financing for a limited time.
The offer is good from May 10 through May 31 according to the website.
With $13,500 in savings on the Model Y, the price is listed at $399 per month for the Model Y Long Range Rear-Wheel Drive model.
The financing rate is good for up to 72 months with $4,250 down and for qualified U.S. customers.
With federal tax credits and 5-year estimated gas savings, the Rear-Wheel Drive Model Y is listed at a starting price of $31,490 and the All-Wheel Drive is listed at $34,490.
Without the credits, the starting price for the Rear-Wheel Drive Model Y is $44,990 and the All-Wheel Drive version is $47,990.
Related Link: <a href="https://www.benzinga.com/news/earnings/24/04/38390883/tesla-q1-earnings-highlights-ev-giant-misses-wall-street-estimates-makes-cost-cuts-invests-in-ai-sp">Tesla Q1 Earnings Highlights: EV Giant Misses Wall Street Estimates, Makes Cost Cuts, Invests In AI, Speeds Launch Of New Models</a>
Why It's Important: The new financing offer comes as many consumers are seeing higher rates when trying to buy a new vehicle.
The nearly one-month-long deal from Tesla, offered during the middle of its second quarter, aims to boost demand for the Model Y.
The Model Y was the bestselling vehicle in 2023 globally and is the<a href="https://www.benzinga.com/24/01/36496558/tesla-model-y-is-bestselling-electric-vehicle-of-all-time-passing-a-record-previously-held-by-the-mu"> top-selling electric vehicle</a> of all time.
Tesla fell short of Wall Street&#8217;s consensus estimates for first quarter deliveries. The latest financing offer,<a href="https://www.benzinga.com/news/24/05/38753412/you-can-now-save-1-000-on-your-7-seat-tesla-model-y-but-theres-a-small-catch"> following several previous deals</a>, may be intended to enhance second-quarter figures.
The electric vehicle company previously said that its 2024 vehicle growth rate would be "notably lower" than the 2023 growth rate.
TSLA Price Action: Tesla shares are up 2% to $172.39 on Monday versus a 52-week trading range of $138.80 to $299.29.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38411281/8-tesla-analysts-size-up-next-gen-vehicles-fsd-ai-and-more-potential-to-be-a-transf">8 Tesla Analysts Size Up Next-Gen Vehicles, FSD, AI And More: &#8216;Potential To Be A Transformational Technology Company, Deliver Outsized Returns&#8217;</a>
Image generated using artificial intelligence via Midjourney.

TSLA

Tesla Defies Auto Industry Trends With 0.99% APR Model Y Financing Offer

Arweave's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AR</a>) price has decreased 8.48% over the past 24 hours to $38.81, continuing its downward trend over the past week of -3.0%, moving from $40.34 to its current price. 
The chart below compares the price movement and volatility for Arweave over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1715626942_0.png" alt="price_chart" />
Arweave's trading volume has climbed 2.0% over the past week along with the circulating supply of the coin, which has increased 0.74%. This brings the circulating supply to 65.45 million, which makes up an estimated 99.17% of its max supply of 66.00 million. According to our data, the current market cap ranking for AR is #48 at $2.53 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1715626943_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

Cryptocurrency Arweave Decreases More Than 8% Within 24 hours

Barrington Research analyst Vincent Colicchio maintains Information Servs Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/III#NASDAQ">III</a>) with a Outperform and lowers the price target from $5 to $3.5.

Barrington Research Maintains Outperform on Information Servs Gr, Lowers Price Target to $3.5

Deep-pocketed investors have adopted a bearish approach towards Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COST usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 49 extraordinary options activities for Costco Wholesale. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 26% leaning bullish and 48% bearish. Among these notable options, 14 are puts, totaling $1,435,780, and 35 are calls, amounting to $2,538,695.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $355.0 to $890.0 for Costco Wholesale over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Costco Wholesale's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Costco Wholesale's whale activity within a strike price range from $355.0 to $890.0 in the last 30 days. 
<h3>Costco Wholesale Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715626881_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$98.95</td>
<td>$95.8</td>
<td>$99.29</td>
<td>$855.00</td>
<td>$505.8K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$41.35</td>
<td>$40.6</td>
<td>$41.35</td>
<td>$780.00</td>
<td>$206.7K</td>
<td style="text-align: right;">70</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>COST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/07/24</td>
<td>$12.8</td>
<td>$12.65</td>
<td>$12.65</td>
<td>$800.00</td>
<td>$197.3K</td>
<td style="text-align: right;">58</td>
<td style="text-align: right;">358</td>
</tr>
<tr>
<td>COST</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$239.05</td>
<td>$232.15</td>
<td>$235.25</td>
<td>$575.00</td>
<td>$188.2K</td>
<td style="text-align: right;">771</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>COST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$288.9</td>
<td>$285.5</td>
<td>$285.5</td>
<td>$500.00</td>
<td>$142.7K</td>
<td style="text-align: right;">23</td>
<td style="text-align: right;">5</td>
</tr>
</tbody>
</table>

<h3>About Costco Wholesale</h3>
Costco operates a membership-based, no-frills retail model, predicated on offering a select product assortment in bulk quantities at bargain prices. The firm avoids maintaining costly product displays by keeping inventory on pallets and limits distribution expenses by storing its inventory at point of sale in the warehouse. Given Costco's frugal cost structure, the firm is able to price its merchandise below competing retailers, driving high sales volume per warehouse and allowing the retailer to generate strong profits on thin margins. Costco operates over 600 warehouses in the United States and boasts over 60% market share in the domestic warehouse club industry. Internationally, Costco operates another 270 warehouses, primarily in markets such as Canada, Mexico, Japan, and the UK.
Following our analysis of the options activities associated with Costco Wholesale, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Costco Wholesale</h3>
<ul>
<li>Currently trading with a volume of 901,049, the COST's price is down by -1.44%, now at $775.86. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 17 days.</li>
</ul>
<h3>What Analysts Are Saying About Costco Wholesale</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $775.0.
<ul>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Neutral rating for Costco Wholesale, targeting a price of $710. </li>
<li>Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Costco Wholesale, targeting a price of $800. </li>
<li>An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Costco Wholesale, which currently sits at a price target of $790. </li>
<li>An analyst from Telsey Advisory Group has decided to maintain their Outperform rating on Costco Wholesale, which currently sits at a price target of $800. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Costco Wholesale with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On Costco Wholesale

Investors with a lot of money to spend have taken a bullish stance on Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DIS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Walt Disney.
This isn't normal.
The overall sentiment of these big-money traders is split between 58% bullish and 23%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $478,368, and 10 are calls, for a total amount of $445,702.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $145.0 for Walt Disney over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Walt Disney stands at 5334.09, with a total volume reaching 8,274.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Walt Disney, situated within the strike price corridor from $75.0 to $145.0, throughout the last 30 days.
<h3>Walt Disney Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715626876_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.35</td>
<td>$11.25</td>
<td>$11.25</td>
<td>$110.00</td>
<td>$120.3K</td>
<td>2.8K</td>
<td style="text-align: right;">107</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.35</td>
<td>$11.2</td>
<td>$11.25</td>
<td>$110.00</td>
<td>$118.1K</td>
<td>2.8K</td>
<td style="text-align: right;">212</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$1.15</td>
<td>$1.09</td>
<td>$1.15</td>
<td>$115.00</td>
<td>$92.0K</td>
<td>4.3K</td>
<td style="text-align: right;">803</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$22.4</td>
<td>$21.9</td>
<td>$22.4</td>
<td>$125.00</td>
<td>$73.9K</td>
<td>610</td>
<td style="text-align: right;">38</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$33.6</td>
<td>$33.4</td>
<td>$33.6</td>
<td>$75.00</td>
<td>$67.2K</td>
<td>1.1K</td>
<td style="text-align: right;">20</td>
</tr>
</tbody>
</table>

<h3>About Walt Disney</h3>
Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from franchises and characters the firm has created over the course of a century. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses ESPN and the ESPN+ streaming service. Experiences contains Disney's theme parks and vacation destinations, and also benefits from merchandise licensing.
Having examined the options trading patterns of Walt Disney, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Walt Disney</h3>
<ul>
<li>Currently trading with a volume of 6,660,249, the DIS's price is up by 0.08%, now at $105.88. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 86 days.</li>
</ul>
<h3>What The Experts Say On Walt Disney</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $133.8.
<ul>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Walt Disney, targeting a price of $141. </li>
<li>Consistent in their evaluation, an analyst from Loop Capital keeps a Buy rating on Walt Disney with a target price of $140. </li>
<li>Consistent in their evaluation, an analyst from Deutsche Bank keeps a Buy rating on Walt Disney with a target price of $130. </li>
<li>An analyst from UBS has decided to maintain their Buy rating on Walt Disney, which currently sits at a price target of $130. </li>
<li>An analyst from Evercore ISI Group persists with their Outperform rating on Walt Disney, maintaining a target price of $128. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Walt Disney options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

A Closer Look at Walt Disney's Options Market Dynamics

Nanalysis Scientific Corp (TSE:NSCI) has released an update. Nanalysis Scientific Corp. successfully completed a prospectus exempt offering and con...

Nanalysis Completes Multimillion-Dollar Funding Round

In a report released today, Stefan Quenneville from Echelon Wealth Partners maintained a Buy rating on Nanalysis Scientific (NSCIF – Research Repor...

Nanalysis Scientific: Buy Rating Affirmed Despite Price Target Adjustment

Nanalysis Scientific Corp (TSE:NSCI) has released an update. Nanalysis Scientific Corp. has secured up to $1.45 million in funding from the Nationa...

Nanalysis Gains Funding for AI Drug Detection Tech

Nanalysis Scientific Corp (TSE:NSCI) has released an update. Nanalysis Scientific Corp., a company specializing in portable Nuclear Magnetic Resona...

Nanalysis Scientific Director Steps Down

Nanalysis Scientific Corp (TSE:NSCI) has released an update. Nanalysis Scientific Corp. has scheduled a conference call for April 25th to discuss t...

Nanalysis Set to Discuss 2023 Financial Results

Nanalysis Scientific Corp (TSE:NSCI) has released an update. Nanalysis Scientific Corp., renowned for its portable NMR machines and MRI technology,...

Nanalysis Sets New Dates for Earnings Call

Nanalysis Scientific Corp (TSE:NSCI) has released an update. Nanalysis Scientific Corp. reported a 36% increase in consolidated revenue for Q4 2023...

Nanalysis Observes Revenue Growth Amid Losses

Nanalysis Scientific Corp. (NSCIF) Q4 2023 Earnings Call Transcript

There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Lantronix (LTRX – Research Report), Harmonic (HLIT –...

Analysts' Top Technology Picks: Lantronix (LTRX), Harmonic (HLIT)

Nanalysis Scientific reports Q4 results

HLIT

LTRX

Press Releases

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances